On May 22, 2006, Mentor (NYSE:MNT) released fiscal year 2006 earnings for the year ended March 31.
- For the full year, revenue beat expectations when including discontinued operations, but earnings per share missed.
- For FY 2007, expect stock-based compensation costs of $0.17 per share, far above the $0.03 impact to FY 2006, as Mentor implements the new reporting requirement.
- Revenue guidance for FY 2007 was $290 to $305 million for continuing operations, an increase of 11% over the just-ended year. No earnings guidance, though.
(Figures in thousands, except per-share data)
Income Statement Highlights|
Avg. Est. |
FY 2006 |
FY 2005 |
Change | |
|---|---|---|---|---|
|
Sales* |
$502,000 |
$268,272 |
$251,726 |
6.6% |
|
Net Profit** |
-- |
$62,357 |
$54,881 |
13.6% |
|
EPS |
$1.46 |
$1.29 |
$1.17 |
10.3% |
|
Diluted Shares |
50,870 |
49,667 |
2.4% |
** GAAP net profit. Not including discontinued, FY 2006 = $48,079 or $1.29 EPS and Q4 2005 = $42,808 or $1.17 EPS.
Get back to basics with a look at the income statement.
Margin Checkup|
FY 2006 |
FY 2005 |
Change* | |
|---|---|---|---|
|
Gross Margin |
74.2% |
74.35% |
(0.14) |
|
Operating Margin |
25.74% |
25.97% |
(0.23) |
|
Net Margin ** |
23.24% |
21.8% |
1.44 |
** Including discontinued operations.
Margins are the earnings engine. See how they work.
Balance Sheet Highlights|
Assets |
Q4 2006 |
Q4 2005 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$200,954 |
$112,894 |
78% |
|
Accounts Rec. |
$58,199 |
$57,218 |
1.7% |
|
Inventory |
$35,219 |
$35,041 |
0.5% |
|
Liabilities |
Q4 2006 |
Q4 2005 |
Change |
|---|---|---|---|
|
Long Term Debt* |
$164,000 |
$150,970 |
8.6% |
Learn the ways of the balance sheet.
Cash Flow Highlights
No cash flow data provided. Boo!
Find out why Fools always follow the money.
Related Companies:
- Medicis Pharmaceutical (NYSE:MRX)
- Inamed, a subsidiary of Allergan (NASDAQ:AGN)
- Johnson & Johnson (NYSE:JNJ)
Related Foolishness:
- Mentor's earnings prediction.
- Last quarter's holding pattern.
- Mentor may be just right for Anna Nicole.
Johnson & Johnson is a Motley Fool Income Investor selection. Want toget paid to invest? Mathew Emmert and the Income Investor team can show you how. Sign up today for a free30-day guest pass.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean.
At the time of publication, Jim Mueller had positions in Johnson & Johnson. Fool rules are here.
